Dave Ricks, CEO of Eli Lilly, on GLP-1s and the business of pharma
Cheeky Pint
Nov 11
Dave Ricks, CEO of Eli Lilly, on GLP-1s and the business of pharma
Dave Ricks, CEO of Eli Lilly, on GLP-1s and the business of pharma

Cheeky Pint
Nov 11
Unprocessed episode, you can be the first!
Shownote
Shownote
Dave Ricks, the CEO of Eli Lilly, the world's most valuable pharmaceutical company, sits down with John and Patrick to discuss the complex business of drug development. Dave explains the true origin story of GLP-1s (from Gila monster saliva), why their pot...
Highlights
Highlights
Chapters
Chapters
Transcript
Transcript